Global Codeine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Codeine market size is predicted to grow from US$ 239 million in 2025 to US$ 168 million in 2031; it is expected to grow at a CAGR of -5.7% from 2025 to 2031.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
LP Information, Inc. (LPI) ' newest research report, the “Codeine Industry Forecast” looks at past sales and reviews total world Codeine sales in 2024, providing a comprehensive analysis by region and market sector of projected Codeine sales for 2025 through 2031. With Codeine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Codeine industry.
This Insight Report provides a comprehensive analysis of the global Codeine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Codeine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Codeine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Codeine and breaks down the forecast by Ingredient, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Codeine.
This report presents a comprehensive overview, market shares, and growth opportunities of Codeine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Ingredient:
What is the 10-year outlook for the global Codeine market?
What factors are driving Codeine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Codeine market opportunities vary by end market size?
How does Codeine break out by Ingredient, by Application?
The global Codeine market size is predicted to grow from US$ 239 million in 2025 to US$ 168 million in 2031; it is expected to grow at a CAGR of -5.7% from 2025 to 2031.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
LP Information, Inc. (LPI) ' newest research report, the “Codeine Industry Forecast” looks at past sales and reviews total world Codeine sales in 2024, providing a comprehensive analysis by region and market sector of projected Codeine sales for 2025 through 2031. With Codeine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Codeine industry.
This Insight Report provides a comprehensive analysis of the global Codeine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Codeine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Codeine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Codeine and breaks down the forecast by Ingredient, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Codeine.
This report presents a comprehensive overview, market shares, and growth opportunities of Codeine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Ingredient:
- Single-ingredient Codeine
- Multi-ingredient Medications
- Narcotic Analgesic
- Antitussive
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Taiji
- Mallinckrodt
- TEVA
- Johnson & Johnson
- Medreich
- Sanofi Aventis
- Cipla
- Hikma
- Pharmaceutical Associates
- Novartis
- Apotex
- Mylan
- Aristo Pharma GmbH
- Lannett Company
- Laboratoire Riva
What is the 10-year outlook for the global Codeine market?
What factors are driving Codeine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Codeine market opportunities vary by end market size?
How does Codeine break out by Ingredient, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Codeine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Codeine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Codeine by Country/Region, 2020, 2024 & 2031
2.2 Codeine Segment by Ingredient
2.2.1 Single-ingredient Codeine
2.2.2 Multi-ingredient Medications
2.3 Codeine Sales by Ingredient
2.3.1 Global Codeine Sales Market Share by Ingredient (2020-2025)
2.3.2 Global Codeine Revenue and Market Share by Ingredient (2020-2025)
2.3.3 Global Codeine Sale Price by Ingredient (2020-2025)
2.4 Codeine Segment by Application
2.4.1 Narcotic Analgesic
2.4.2 Antitussive
2.4.3 Others
2.5 Codeine Sales by Application
2.5.1 Global Codeine Sale Market Share by Application (2020-2025)
2.5.2 Global Codeine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Codeine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Codeine Breakdown Data by Company
3.1.1 Global Codeine Annual Sales by Company (2020-2025)
3.1.2 Global Codeine Sales Market Share by Company (2020-2025)
3.2 Global Codeine Annual Revenue by Company (2020-2025)
3.2.1 Global Codeine Revenue by Company (2020-2025)
3.2.2 Global Codeine Revenue Market Share by Company (2020-2025)
3.3 Global Codeine Sale Price by Company
3.4 Key Manufacturers Codeine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Codeine Product Location Distribution
3.4.2 Players Codeine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CODEINE BY GEOGRAPHIC REGION
4.1 World Historic Codeine Market Size by Geographic Region (2020-2025)
4.1.1 Global Codeine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Codeine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Codeine Market Size by Country/Region (2020-2025)
4.2.1 Global Codeine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Codeine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Codeine Sales Growth
4.4 APAC Codeine Sales Growth
4.5 Europe Codeine Sales Growth
4.6 Middle East & Africa Codeine Sales Growth
5 AMERICAS
5.1 Americas Codeine Sales by Country
5.1.1 Americas Codeine Sales by Country (2020-2025)
5.1.2 Americas Codeine Revenue by Country (2020-2025)
5.2 Americas Codeine Sales by Ingredient (2020-2025)
5.3 Americas Codeine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Codeine Sales by Region
6.1.1 APAC Codeine Sales by Region (2020-2025)
6.1.2 APAC Codeine Revenue by Region (2020-2025)
6.2 APAC Codeine Sales by Ingredient (2020-2025)
6.3 APAC Codeine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Codeine by Country
7.1.1 Europe Codeine Sales by Country (2020-2025)
7.1.2 Europe Codeine Revenue by Country (2020-2025)
7.2 Europe Codeine Sales by Ingredient (2020-2025)
7.3 Europe Codeine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Codeine by Country
8.1.1 Middle East & Africa Codeine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Codeine Revenue by Country (2020-2025)
8.2 Middle East & Africa Codeine Sales by Ingredient (2020-2025)
8.3 Middle East & Africa Codeine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Codeine
10.3 Manufacturing Process Analysis of Codeine
10.4 Industry Chain Structure of Codeine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Codeine Distributors
11.3 Codeine Customer
12 WORLD FORECAST REVIEW FOR CODEINE BY GEOGRAPHIC REGION
12.1 Global Codeine Market Size Forecast by Region
12.1.1 Global Codeine Forecast by Region (2026-2031)
12.1.2 Global Codeine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Codeine Forecast by Ingredient (2026-2031)
12.7 Global Codeine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Taiji
13.1.1 Taiji Company Information
13.1.2 Taiji Codeine Product Portfolios and Specifications
13.1.3 Taiji Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Taiji Main Business Overview
13.1.5 Taiji Latest Developments
13.2 Mallinckrodt
13.2.1 Mallinckrodt Company Information
13.2.2 Mallinckrodt Codeine Product Portfolios and Specifications
13.2.3 Mallinckrodt Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mallinckrodt Main Business Overview
13.2.5 Mallinckrodt Latest Developments
13.3 TEVA
13.3.1 TEVA Company Information
13.3.2 TEVA Codeine Product Portfolios and Specifications
13.3.3 TEVA Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TEVA Main Business Overview
13.3.5 TEVA Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Codeine Product Portfolios and Specifications
13.4.3 Johnson & Johnson Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Medreich
13.5.1 Medreich Company Information
13.5.2 Medreich Codeine Product Portfolios and Specifications
13.5.3 Medreich Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Medreich Main Business Overview
13.5.5 Medreich Latest Developments
13.6 Sanofi Aventis
13.6.1 Sanofi Aventis Company Information
13.6.2 Sanofi Aventis Codeine Product Portfolios and Specifications
13.6.3 Sanofi Aventis Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sanofi Aventis Main Business Overview
13.6.5 Sanofi Aventis Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Codeine Product Portfolios and Specifications
13.7.3 Cipla Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Hikma
13.8.1 Hikma Company Information
13.8.2 Hikma Codeine Product Portfolios and Specifications
13.8.3 Hikma Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hikma Main Business Overview
13.8.5 Hikma Latest Developments
13.9 Pharmaceutical Associates
13.9.1 Pharmaceutical Associates Company Information
13.9.2 Pharmaceutical Associates Codeine Product Portfolios and Specifications
13.9.3 Pharmaceutical Associates Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pharmaceutical Associates Main Business Overview
13.9.5 Pharmaceutical Associates Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Codeine Product Portfolios and Specifications
13.10.3 Novartis Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Apotex
13.11.1 Apotex Company Information
13.11.2 Apotex Codeine Product Portfolios and Specifications
13.11.3 Apotex Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Apotex Main Business Overview
13.11.5 Apotex Latest Developments
13.12 Mylan
13.12.1 Mylan Company Information
13.12.2 Mylan Codeine Product Portfolios and Specifications
13.12.3 Mylan Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Mylan Main Business Overview
13.12.5 Mylan Latest Developments
13.13 Aristo Pharma GmbH
13.13.1 Aristo Pharma GmbH Company Information
13.13.2 Aristo Pharma GmbH Codeine Product Portfolios and Specifications
13.13.3 Aristo Pharma GmbH Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Aristo Pharma GmbH Main Business Overview
13.13.5 Aristo Pharma GmbH Latest Developments
13.14 Lannett Company
13.14.1 Lannett Company Company Information
13.14.2 Lannett Company Codeine Product Portfolios and Specifications
13.14.3 Lannett Company Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Lannett Company Main Business Overview
13.14.5 Lannett Company Latest Developments
13.15 Laboratoire Riva
13.15.1 Laboratoire Riva Company Information
13.15.2 Laboratoire Riva Codeine Product Portfolios and Specifications
13.15.3 Laboratoire Riva Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Laboratoire Riva Main Business Overview
13.15.5 Laboratoire Riva Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Codeine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Codeine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Single-ingredient Codeine
Table 4. Major Players of Multi-ingredient Medications
Table 5. Global Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 6. Global Codeine Sales Market Share by Ingredient (2020-2025)
Table 7. Global Codeine Revenue by Ingredient (2020-2025) & ($ million)
Table 8. Global Codeine Revenue Market Share by Ingredient (2020-2025)
Table 9. Global Codeine Sale Price by Ingredient (2020-2025) & (USD/Unit)
Table 10. Global Codeine Sale by Application (2020-2025) & (M Units)
Table 11. Global Codeine Sale Market Share by Application (2020-2025)
Table 12. Global Codeine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Codeine Revenue Market Share by Application (2020-2025)
Table 14. Global Codeine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Codeine Sales by Company (2020-2025) & (M Units)
Table 16. Global Codeine Sales Market Share by Company (2020-2025)
Table 17. Global Codeine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Codeine Revenue Market Share by Company (2020-2025)
Table 19. Global Codeine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Codeine Producing Area Distribution and Sales Area
Table 21. Players Codeine Products Offered
Table 22. Codeine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Codeine Sales by Geographic Region (2020-2025) & (M Units)
Table 26. Global Codeine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Codeine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Codeine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Codeine Sales by Country/Region (2020-2025) & (M Units)
Table 30. Global Codeine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Codeine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Codeine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Codeine Sales by Country (2020-2025) & (M Units)
Table 34. Americas Codeine Sales Market Share by Country (2020-2025)
Table 35. Americas Codeine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 37. Americas Codeine Sales by Application (2020-2025) & (M Units)
Table 38. APAC Codeine Sales by Region (2020-2025) & (M Units)
Table 39. APAC Codeine Sales Market Share by Region (2020-2025)
Table 40. APAC Codeine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 42. APAC Codeine Sales by Application (2020-2025) & (M Units)
Table 43. Europe Codeine Sales by Country (2020-2025) & (M Units)
Table 44. Europe Codeine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 46. Europe Codeine Sales by Application (2020-2025) & (M Units)
Table 47. Middle East & Africa Codeine Sales by Country (2020-2025) & (M Units)
Table 48. Middle East & Africa Codeine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 50. Middle East & Africa Codeine Sales by Application (2020-2025) & (M Units)
Table 51. Key Market Drivers & Growth Opportunities of Codeine
Table 52. Key Market Challenges & Risks of Codeine
Table 53. Key IndustryTrends of Codeine
Table 54. Codeine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Codeine Distributors List
Table 57. Codeine Customer List
Table 58. Global Codeine SalesForecast by Region (2026-2031) & (M Units)
Table 59. Global Codeine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Codeine SalesForecast by Country (2026-2031) & (M Units)
Table 61. Americas Codeine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Codeine SalesForecast by Region (2026-2031) & (M Units)
Table 63. APAC Codeine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Codeine SalesForecast by Country (2026-2031) & (M Units)
Table 65. Europe Codeine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Codeine SalesForecast by Country (2026-2031) & (M Units)
Table 67. Middle East & Africa Codeine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Codeine SalesForecast by Ingredient (2026-2031) & (M Units)
Table 69. Global Codeine RevenueForecast by Ingredient (2026-2031) & ($ millions)
Table 70. Global Codeine SalesForecast by Application (2026-2031) & (M Units)
Table 71. Global Codeine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72.Taiji Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 73.Taiji Codeine Product Portfolios and Specifications
Table 74.Taiji Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75.Taiji Main Business
Table 76.Taiji Latest Developments
Table 77. Mallinckrodt Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 78. Mallinckrodt Codeine Product Portfolios and Specifications
Table 79. Mallinckrodt Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Mallinckrodt Main Business
Table 81. Mallinckrodt Latest Developments
Table 82.TEVA Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 83.TEVA Codeine Product Portfolios and Specifications
Table 84.TEVA Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85.TEVA Main Business
Table 86.TEVA Latest Developments
Table 87. Johnson & Johnson Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 88. Johnson & Johnson Codeine Product Portfolios and Specifications
Table 89. Johnson & Johnson Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Johnson & Johnson Main Business
Table 91. Johnson & Johnson Latest Developments
Table 92. Medreich Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 93. Medreich Codeine Product Portfolios and Specifications
Table 94. Medreich Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Medreich Main Business
Table 96. Medreich Latest Developments
Table 97. Sanofi Aventis Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Aventis Codeine Product Portfolios and Specifications
Table 99. Sanofi Aventis Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Sanofi Aventis Main Business
Table 101. Sanofi Aventis Latest Developments
Table 102. Cipla Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 103. Cipla Codeine Product Portfolios and Specifications
Table 104. Cipla Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Cipla Main Business
Table 106. Cipla Latest Developments
Table 107. Hikma Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 108. Hikma Codeine Product Portfolios and Specifications
Table 109. Hikma Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Hikma Main Business
Table 111. Hikma Latest Developments
Table 112. Pharmaceutical Associates Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 113. Pharmaceutical Associates Codeine Product Portfolios and Specifications
Table 114. Pharmaceutical Associates Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Pharmaceutical Associates Main Business
Table 116. Pharmaceutical Associates Latest Developments
Table 117. Novartis Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Codeine Product Portfolios and Specifications
Table 119. Novartis Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. Apotex Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 123. Apotex Codeine Product Portfolios and Specifications
Table 124. Apotex Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Apotex Main Business
Table 126. Apotex Latest Developments
Table 127. Mylan Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 128. Mylan Codeine Product Portfolios and Specifications
Table 129. Mylan Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Mylan Main Business
Table 131. Mylan Latest Developments
Table 132. Aristo Pharma GmbH Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 133. Aristo Pharma GmbH Codeine Product Portfolios and Specifications
Table 134. Aristo Pharma GmbH Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Aristo Pharma GmbH Main Business
Table 136. Aristo Pharma GmbH Latest Developments
Table 137. Lannett Company Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 138. Lannett Company Codeine Product Portfolios and Specifications
Table 139. Lannett Company Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Lannett Company Main Business
Table 141. Lannett Company Latest Developments
Table 142. Laboratoire Riva Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 143. Laboratoire Riva Codeine Product Portfolios and Specifications
Table 144. Laboratoire Riva Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Laboratoire Riva Main Business
Table 146. Laboratoire Riva Latest Developments
LIST OFFIGURES
Figure 1. Picture of Codeine
Figure 2. Codeine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Codeine Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Codeine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Codeine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Codeine Sales Market Share by Country/Region (2024)
Figure 10. Codeine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Single-ingredient Codeine
Figure 12. Product Picture of Multi-ingredient Medications
Figure 13. Global Codeine Sales Market Share by Ingredient in 2025
Figure 14. Global Codeine Revenue Market Share by Ingredient (2020-2025)
Figure 15. Codeine Consumed in Narcotic Analgesic
Figure 16. Global Codeine Market: Narcotic Analgesic (2020-2025) & (M Units)
Figure 17. Codeine Consumed in Antitussive
Figure 18. Global Codeine Market: Antitussive (2020-2025) & (M Units)
Figure 19. Codeine Consumed in Others
Figure 20. Global Codeine Market: Others (2020-2025) & (M Units)
Figure 21. Global Codeine Sale Market Share by Application (2024)
Figure 22. Global Codeine Revenue Market Share by Application in 2025
Figure 23. Codeine Sales by Company in 2025 (M Units)
Figure 24. Global Codeine Sales Market Share by Company in 2025
Figure 25. Codeine Revenue by Company in 2025 ($ millions)
Figure 26. Global Codeine Revenue Market Share by Company in 2025
Figure 27. Global Codeine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Codeine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Codeine Sales 2020-2025 (M Units)
Figure 30. Americas Codeine Revenue 2020-2025 ($ millions)
Figure 31. APAC Codeine Sales 2020-2025 (M Units)
Figure 32. APAC Codeine Revenue 2020-2025 ($ millions)
Figure 33. Europe Codeine Sales 2020-2025 (M Units)
Figure 34. Europe Codeine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Codeine Sales 2020-2025 (M Units)
Figure 36. Middle East & Africa Codeine Revenue 2020-2025 ($ millions)
Figure 37. Americas Codeine Sales Market Share by Country in 2025
Figure 38. Americas Codeine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Codeine Sales Market Share by Ingredient (2020-2025)
Figure 40. Americas Codeine Sales Market Share by Application (2020-2025)
Figure 41. United States Codeine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Codeine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Codeine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Codeine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Codeine Sales Market Share by Region in 2025
Figure 46. APAC Codeine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Codeine Sales Market Share by Ingredient (2020-2025)
Figure 48. APAC Codeine Sales Market Share by Application (2020-2025)
Figure 49. China Codeine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Codeine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Codeine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Codeine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Codeine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Codeine Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Codeine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Codeine Sales Market Share by Country in 2025
Figure 57. Europe Codeine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Codeine Sales Market Share by Ingredient (2020-2025)
Figure 59. Europe Codeine Sales Market Share by Application (2020-2025)
Figure 60. Germany Codeine Revenue Growth 2020-2025 ($ millions)
Figure 61.France Codeine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Codeine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Codeine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Codeine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Codeine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Codeine Sales Market Share by Ingredient (2020-2025)
Figure 67. Middle East & Africa Codeine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Codeine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Codeine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Codeine Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Codeine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Codeine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Codeine in 2025
Figure 74. Manufacturing Process Analysis of Codeine
Figure 75. Industry Chain Structure of Codeine
Figure 76. Channels of Distribution
Figure 77. Global Codeine Sales MarketForecast by Region (2026-2031)
Figure 78. Global Codeine Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Codeine Sales Market ShareForecast by Ingredient (2026-2031)
Figure 80. Global Codeine Revenue Market ShareForecast by Ingredient (2026-2031)
Figure 81. Global Codeine Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Codeine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Codeine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Codeine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Codeine by Country/Region, 2020, 2024 & 2031
2.2 Codeine Segment by Ingredient
2.2.1 Single-ingredient Codeine
2.2.2 Multi-ingredient Medications
2.3 Codeine Sales by Ingredient
2.3.1 Global Codeine Sales Market Share by Ingredient (2020-2025)
2.3.2 Global Codeine Revenue and Market Share by Ingredient (2020-2025)
2.3.3 Global Codeine Sale Price by Ingredient (2020-2025)
2.4 Codeine Segment by Application
2.4.1 Narcotic Analgesic
2.4.2 Antitussive
2.4.3 Others
2.5 Codeine Sales by Application
2.5.1 Global Codeine Sale Market Share by Application (2020-2025)
2.5.2 Global Codeine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Codeine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Codeine Breakdown Data by Company
3.1.1 Global Codeine Annual Sales by Company (2020-2025)
3.1.2 Global Codeine Sales Market Share by Company (2020-2025)
3.2 Global Codeine Annual Revenue by Company (2020-2025)
3.2.1 Global Codeine Revenue by Company (2020-2025)
3.2.2 Global Codeine Revenue Market Share by Company (2020-2025)
3.3 Global Codeine Sale Price by Company
3.4 Key Manufacturers Codeine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Codeine Product Location Distribution
3.4.2 Players Codeine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CODEINE BY GEOGRAPHIC REGION
4.1 World Historic Codeine Market Size by Geographic Region (2020-2025)
4.1.1 Global Codeine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Codeine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Codeine Market Size by Country/Region (2020-2025)
4.2.1 Global Codeine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Codeine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Codeine Sales Growth
4.4 APAC Codeine Sales Growth
4.5 Europe Codeine Sales Growth
4.6 Middle East & Africa Codeine Sales Growth
5 AMERICAS
5.1 Americas Codeine Sales by Country
5.1.1 Americas Codeine Sales by Country (2020-2025)
5.1.2 Americas Codeine Revenue by Country (2020-2025)
5.2 Americas Codeine Sales by Ingredient (2020-2025)
5.3 Americas Codeine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Codeine Sales by Region
6.1.1 APAC Codeine Sales by Region (2020-2025)
6.1.2 APAC Codeine Revenue by Region (2020-2025)
6.2 APAC Codeine Sales by Ingredient (2020-2025)
6.3 APAC Codeine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Codeine by Country
7.1.1 Europe Codeine Sales by Country (2020-2025)
7.1.2 Europe Codeine Revenue by Country (2020-2025)
7.2 Europe Codeine Sales by Ingredient (2020-2025)
7.3 Europe Codeine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Codeine by Country
8.1.1 Middle East & Africa Codeine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Codeine Revenue by Country (2020-2025)
8.2 Middle East & Africa Codeine Sales by Ingredient (2020-2025)
8.3 Middle East & Africa Codeine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Codeine
10.3 Manufacturing Process Analysis of Codeine
10.4 Industry Chain Structure of Codeine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Codeine Distributors
11.3 Codeine Customer
12 WORLD FORECAST REVIEW FOR CODEINE BY GEOGRAPHIC REGION
12.1 Global Codeine Market Size Forecast by Region
12.1.1 Global Codeine Forecast by Region (2026-2031)
12.1.2 Global Codeine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Codeine Forecast by Ingredient (2026-2031)
12.7 Global Codeine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Taiji
13.1.1 Taiji Company Information
13.1.2 Taiji Codeine Product Portfolios and Specifications
13.1.3 Taiji Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Taiji Main Business Overview
13.1.5 Taiji Latest Developments
13.2 Mallinckrodt
13.2.1 Mallinckrodt Company Information
13.2.2 Mallinckrodt Codeine Product Portfolios and Specifications
13.2.3 Mallinckrodt Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mallinckrodt Main Business Overview
13.2.5 Mallinckrodt Latest Developments
13.3 TEVA
13.3.1 TEVA Company Information
13.3.2 TEVA Codeine Product Portfolios and Specifications
13.3.3 TEVA Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TEVA Main Business Overview
13.3.5 TEVA Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Codeine Product Portfolios and Specifications
13.4.3 Johnson & Johnson Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Medreich
13.5.1 Medreich Company Information
13.5.2 Medreich Codeine Product Portfolios and Specifications
13.5.3 Medreich Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Medreich Main Business Overview
13.5.5 Medreich Latest Developments
13.6 Sanofi Aventis
13.6.1 Sanofi Aventis Company Information
13.6.2 Sanofi Aventis Codeine Product Portfolios and Specifications
13.6.3 Sanofi Aventis Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sanofi Aventis Main Business Overview
13.6.5 Sanofi Aventis Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Codeine Product Portfolios and Specifications
13.7.3 Cipla Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Hikma
13.8.1 Hikma Company Information
13.8.2 Hikma Codeine Product Portfolios and Specifications
13.8.3 Hikma Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hikma Main Business Overview
13.8.5 Hikma Latest Developments
13.9 Pharmaceutical Associates
13.9.1 Pharmaceutical Associates Company Information
13.9.2 Pharmaceutical Associates Codeine Product Portfolios and Specifications
13.9.3 Pharmaceutical Associates Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pharmaceutical Associates Main Business Overview
13.9.5 Pharmaceutical Associates Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Codeine Product Portfolios and Specifications
13.10.3 Novartis Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Apotex
13.11.1 Apotex Company Information
13.11.2 Apotex Codeine Product Portfolios and Specifications
13.11.3 Apotex Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Apotex Main Business Overview
13.11.5 Apotex Latest Developments
13.12 Mylan
13.12.1 Mylan Company Information
13.12.2 Mylan Codeine Product Portfolios and Specifications
13.12.3 Mylan Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Mylan Main Business Overview
13.12.5 Mylan Latest Developments
13.13 Aristo Pharma GmbH
13.13.1 Aristo Pharma GmbH Company Information
13.13.2 Aristo Pharma GmbH Codeine Product Portfolios and Specifications
13.13.3 Aristo Pharma GmbH Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Aristo Pharma GmbH Main Business Overview
13.13.5 Aristo Pharma GmbH Latest Developments
13.14 Lannett Company
13.14.1 Lannett Company Company Information
13.14.2 Lannett Company Codeine Product Portfolios and Specifications
13.14.3 Lannett Company Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Lannett Company Main Business Overview
13.14.5 Lannett Company Latest Developments
13.15 Laboratoire Riva
13.15.1 Laboratoire Riva Company Information
13.15.2 Laboratoire Riva Codeine Product Portfolios and Specifications
13.15.3 Laboratoire Riva Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Laboratoire Riva Main Business Overview
13.15.5 Laboratoire Riva Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Codeine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Codeine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Single-ingredient Codeine
Table 4. Major Players of Multi-ingredient Medications
Table 5. Global Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 6. Global Codeine Sales Market Share by Ingredient (2020-2025)
Table 7. Global Codeine Revenue by Ingredient (2020-2025) & ($ million)
Table 8. Global Codeine Revenue Market Share by Ingredient (2020-2025)
Table 9. Global Codeine Sale Price by Ingredient (2020-2025) & (USD/Unit)
Table 10. Global Codeine Sale by Application (2020-2025) & (M Units)
Table 11. Global Codeine Sale Market Share by Application (2020-2025)
Table 12. Global Codeine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Codeine Revenue Market Share by Application (2020-2025)
Table 14. Global Codeine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Codeine Sales by Company (2020-2025) & (M Units)
Table 16. Global Codeine Sales Market Share by Company (2020-2025)
Table 17. Global Codeine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Codeine Revenue Market Share by Company (2020-2025)
Table 19. Global Codeine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Codeine Producing Area Distribution and Sales Area
Table 21. Players Codeine Products Offered
Table 22. Codeine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Codeine Sales by Geographic Region (2020-2025) & (M Units)
Table 26. Global Codeine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Codeine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Codeine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Codeine Sales by Country/Region (2020-2025) & (M Units)
Table 30. Global Codeine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Codeine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Codeine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Codeine Sales by Country (2020-2025) & (M Units)
Table 34. Americas Codeine Sales Market Share by Country (2020-2025)
Table 35. Americas Codeine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 37. Americas Codeine Sales by Application (2020-2025) & (M Units)
Table 38. APAC Codeine Sales by Region (2020-2025) & (M Units)
Table 39. APAC Codeine Sales Market Share by Region (2020-2025)
Table 40. APAC Codeine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 42. APAC Codeine Sales by Application (2020-2025) & (M Units)
Table 43. Europe Codeine Sales by Country (2020-2025) & (M Units)
Table 44. Europe Codeine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 46. Europe Codeine Sales by Application (2020-2025) & (M Units)
Table 47. Middle East & Africa Codeine Sales by Country (2020-2025) & (M Units)
Table 48. Middle East & Africa Codeine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 50. Middle East & Africa Codeine Sales by Application (2020-2025) & (M Units)
Table 51. Key Market Drivers & Growth Opportunities of Codeine
Table 52. Key Market Challenges & Risks of Codeine
Table 53. Key IndustryTrends of Codeine
Table 54. Codeine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Codeine Distributors List
Table 57. Codeine Customer List
Table 58. Global Codeine SalesForecast by Region (2026-2031) & (M Units)
Table 59. Global Codeine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Codeine SalesForecast by Country (2026-2031) & (M Units)
Table 61. Americas Codeine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Codeine SalesForecast by Region (2026-2031) & (M Units)
Table 63. APAC Codeine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Codeine SalesForecast by Country (2026-2031) & (M Units)
Table 65. Europe Codeine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Codeine SalesForecast by Country (2026-2031) & (M Units)
Table 67. Middle East & Africa Codeine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Codeine SalesForecast by Ingredient (2026-2031) & (M Units)
Table 69. Global Codeine RevenueForecast by Ingredient (2026-2031) & ($ millions)
Table 70. Global Codeine SalesForecast by Application (2026-2031) & (M Units)
Table 71. Global Codeine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72.Taiji Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 73.Taiji Codeine Product Portfolios and Specifications
Table 74.Taiji Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75.Taiji Main Business
Table 76.Taiji Latest Developments
Table 77. Mallinckrodt Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 78. Mallinckrodt Codeine Product Portfolios and Specifications
Table 79. Mallinckrodt Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Mallinckrodt Main Business
Table 81. Mallinckrodt Latest Developments
Table 82.TEVA Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 83.TEVA Codeine Product Portfolios and Specifications
Table 84.TEVA Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85.TEVA Main Business
Table 86.TEVA Latest Developments
Table 87. Johnson & Johnson Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 88. Johnson & Johnson Codeine Product Portfolios and Specifications
Table 89. Johnson & Johnson Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Johnson & Johnson Main Business
Table 91. Johnson & Johnson Latest Developments
Table 92. Medreich Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 93. Medreich Codeine Product Portfolios and Specifications
Table 94. Medreich Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Medreich Main Business
Table 96. Medreich Latest Developments
Table 97. Sanofi Aventis Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Aventis Codeine Product Portfolios and Specifications
Table 99. Sanofi Aventis Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Sanofi Aventis Main Business
Table 101. Sanofi Aventis Latest Developments
Table 102. Cipla Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 103. Cipla Codeine Product Portfolios and Specifications
Table 104. Cipla Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Cipla Main Business
Table 106. Cipla Latest Developments
Table 107. Hikma Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 108. Hikma Codeine Product Portfolios and Specifications
Table 109. Hikma Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Hikma Main Business
Table 111. Hikma Latest Developments
Table 112. Pharmaceutical Associates Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 113. Pharmaceutical Associates Codeine Product Portfolios and Specifications
Table 114. Pharmaceutical Associates Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Pharmaceutical Associates Main Business
Table 116. Pharmaceutical Associates Latest Developments
Table 117. Novartis Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Codeine Product Portfolios and Specifications
Table 119. Novartis Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. Apotex Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 123. Apotex Codeine Product Portfolios and Specifications
Table 124. Apotex Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Apotex Main Business
Table 126. Apotex Latest Developments
Table 127. Mylan Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 128. Mylan Codeine Product Portfolios and Specifications
Table 129. Mylan Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Mylan Main Business
Table 131. Mylan Latest Developments
Table 132. Aristo Pharma GmbH Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 133. Aristo Pharma GmbH Codeine Product Portfolios and Specifications
Table 134. Aristo Pharma GmbH Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Aristo Pharma GmbH Main Business
Table 136. Aristo Pharma GmbH Latest Developments
Table 137. Lannett Company Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 138. Lannett Company Codeine Product Portfolios and Specifications
Table 139. Lannett Company Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Lannett Company Main Business
Table 141. Lannett Company Latest Developments
Table 142. Laboratoire Riva Basic Information, Codeine Manufacturing Base, Sales Area and Its Competitors
Table 143. Laboratoire Riva Codeine Product Portfolios and Specifications
Table 144. Laboratoire Riva Codeine Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Laboratoire Riva Main Business
Table 146. Laboratoire Riva Latest Developments
LIST OFFIGURES
Figure 1. Picture of Codeine
Figure 2. Codeine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Codeine Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Codeine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Codeine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Codeine Sales Market Share by Country/Region (2024)
Figure 10. Codeine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Single-ingredient Codeine
Figure 12. Product Picture of Multi-ingredient Medications
Figure 13. Global Codeine Sales Market Share by Ingredient in 2025
Figure 14. Global Codeine Revenue Market Share by Ingredient (2020-2025)
Figure 15. Codeine Consumed in Narcotic Analgesic
Figure 16. Global Codeine Market: Narcotic Analgesic (2020-2025) & (M Units)
Figure 17. Codeine Consumed in Antitussive
Figure 18. Global Codeine Market: Antitussive (2020-2025) & (M Units)
Figure 19. Codeine Consumed in Others
Figure 20. Global Codeine Market: Others (2020-2025) & (M Units)
Figure 21. Global Codeine Sale Market Share by Application (2024)
Figure 22. Global Codeine Revenue Market Share by Application in 2025
Figure 23. Codeine Sales by Company in 2025 (M Units)
Figure 24. Global Codeine Sales Market Share by Company in 2025
Figure 25. Codeine Revenue by Company in 2025 ($ millions)
Figure 26. Global Codeine Revenue Market Share by Company in 2025
Figure 27. Global Codeine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Codeine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Codeine Sales 2020-2025 (M Units)
Figure 30. Americas Codeine Revenue 2020-2025 ($ millions)
Figure 31. APAC Codeine Sales 2020-2025 (M Units)
Figure 32. APAC Codeine Revenue 2020-2025 ($ millions)
Figure 33. Europe Codeine Sales 2020-2025 (M Units)
Figure 34. Europe Codeine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Codeine Sales 2020-2025 (M Units)
Figure 36. Middle East & Africa Codeine Revenue 2020-2025 ($ millions)
Figure 37. Americas Codeine Sales Market Share by Country in 2025
Figure 38. Americas Codeine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Codeine Sales Market Share by Ingredient (2020-2025)
Figure 40. Americas Codeine Sales Market Share by Application (2020-2025)
Figure 41. United States Codeine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Codeine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Codeine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Codeine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Codeine Sales Market Share by Region in 2025
Figure 46. APAC Codeine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Codeine Sales Market Share by Ingredient (2020-2025)
Figure 48. APAC Codeine Sales Market Share by Application (2020-2025)
Figure 49. China Codeine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Codeine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Codeine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Codeine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Codeine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Codeine Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Codeine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Codeine Sales Market Share by Country in 2025
Figure 57. Europe Codeine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Codeine Sales Market Share by Ingredient (2020-2025)
Figure 59. Europe Codeine Sales Market Share by Application (2020-2025)
Figure 60. Germany Codeine Revenue Growth 2020-2025 ($ millions)
Figure 61.France Codeine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Codeine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Codeine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Codeine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Codeine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Codeine Sales Market Share by Ingredient (2020-2025)
Figure 67. Middle East & Africa Codeine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Codeine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Codeine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Codeine Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Codeine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Codeine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Codeine in 2025
Figure 74. Manufacturing Process Analysis of Codeine
Figure 75. Industry Chain Structure of Codeine
Figure 76. Channels of Distribution
Figure 77. Global Codeine Sales MarketForecast by Region (2026-2031)
Figure 78. Global Codeine Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Codeine Sales Market ShareForecast by Ingredient (2026-2031)
Figure 80. Global Codeine Revenue Market ShareForecast by Ingredient (2026-2031)
Figure 81. Global Codeine Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Codeine Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Anti-Aging Products and Therapies Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2024
96 pages
Global Ashwagandha Extract Market Growth 2026-2032
US$ 3,660.00
May 2026
116 pages
Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
92 pages
Global Endoscope Washer-Disinfectors Market Growth 2025-2031
US$ 3,660.00
March 2025
110 pages
Global Glucose Meter Market Growth 2025-2031
US$ 3,660.00
May 2025
144 pages
